Givaudan | GIVN - Cost Of Sales


Givaudan reported CHF2.07B in Cost of Sales for its fiscal semester ending in December of 2025.





Cost Of Sales Change Date
Air Liquide EUR 5.9B 415.5M Dec/2025
Akzo Nobel EUR 1.41B 28M Mar/2026
Anheuser-Busch USD 6.62B 323M Mar/2026
Arkema EUR 1.8B 4.7M Mar/2026
BASF EUR 11.87B 941M Mar/2026
Bayer EUR 5.23B 731M Mar/2026
Beiersdorf EUR 2.06B 50M Dec/2025
British American Tobacco GBP 3.6B 427M Dec/2025
Covestro EUR 2.7B 5.39B Dec/2025
Croda International GBP 445.5M 221.15M Dec/2024
Danone EUR 6.73B 17M Dec/2025
Diageo GBP 4.08B 166M Dec/2025
Fresenius EUR 4.45B 262M Dec/2025
Fresenius Medical Care EUR 3.43B 248M Mar/2026
Givaudan CHF 2.07B 105M Dec/2025
Heineken EUR 12.71B 288M Dec/2025
Henkel EUR 4.96B 110M Dec/2025
International Flavors Fragrances USD 1.87B 36M Mar/2026
Johnson Matthey GBP 6.9B 1.86B Jun/2026
Lonza CHF 2.28B 189M Jun/2025
L'Oréal EUR 5.62B 71.8M Dec/2025
Merck EUR 2.07B 219M Mar/2026
Nestle CHF 25.08B 1.48B Dec/2025
Pernod Ricard EUR 2.14B 99M Dec/2025
Reckitt Benckiser GBP 2.75B 1.34B Dec/2024
SGS CHF 445M 522M Jun/2025
Sika AG CHF 2.77B 49.8M Dec/2025
Solvay EUR 876M 16M Mar/2026
Umicore EUR 9.76B 1.54B Dec/2025
Victrex GBP 86.8M 6.8M Jun/2026